<DOC>
	<DOCNO>NCT00478504</DOCNO>
	<brief_summary>The primary aim study assess efficacy letrozole ovulation induction agent test hypothesis letrozole generate well pregnancy rate fewer multiple pregnancy higher live birth rate current standard agent , clomifene citrate anovular infertile woman polycystic ovarian syndrome .</brief_summary>
	<brief_title>Letrozole Versus Clomifene Citrate Ovulation Induction</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>1 . Age : 18 39 2 . BMI &lt; 36 3 . Infertility due anovulation 4 . PCOS : At least two follow diagnostic criterion : 1 . Oligo/amenorrhoea 2 . Hyperandrogenaemia : biochemical ( testosterone ≥2.5 nmol/l free androgen index ( FAI ) ≥ 5 ) clinical ( acne/hirsutism ) evidence 3 . USS evidence PCO ( either ≥12 follicles measure 29 mm diameter , ovarian volume &gt; 10 ml ) 5 . No recent ( within 6 month ) treatment induction ovulation 6 . Normal semen analysis ( WHO 1999 ) 7 . Proven patency least one Fallopian tube 1 . Inability give inform consent 2 . Contraindication letrozole clomifene citrate 3 . Absence inclusion criterion</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>anovulation</keyword>
	<keyword>ovulation induction ,</keyword>
	<keyword>polycystic ovarian syndrome</keyword>
	<keyword>clomifene citrate</keyword>
	<keyword>letrozole</keyword>
</DOC>